Presented May News Today

Resynchronization therapy jumps forward with 3 new studies that support but push the envelope of a new guideline statement on physiologic pacing for heart failure.

Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.

Its actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.

In addition to reducing negative symptoms of schizophrenia, music therapy improves sleep and symptoms of depression.

The copper chelator trientine was well tolerated and lowered NT-proBNP levels in patients with heart failure and reduced ejection fraction in a phase 2 study.

A combination of simple interventions for patients with acute hemorrhagic stroke has been shown to significantly improve the chances of survival without major disability.

Hormone replacement therapy for menopausal patients has gone by the wayside as an off-label treatment has picked up prevalence, but should clinicians be wary?

Findings from the first randomized clinical trial of remote pulmonary artery pressure monitoring for patients with chronic heart failure in Europe are "reassuring."

Study shows that children who were exposed to severe, early, psychosocial deprivation benefited substantially from high-quality family-based care.

Patients treated with dupilumab for COPD also showed significant improvements in lung function at 12 and 52 weeks.